XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Additional Information) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Feb. 28, 2013
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Commitments and Contingencies [Line Items]        
Finance lease liabilities   $ 0    
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]   Derivative Liability, Noncurrent    
Lease Expense   $ 200 $ 100  
Product Development Agreement [Member] | Developers [Member]        
Commitments and Contingencies [Line Items]        
Royalty payments   2,200    
Accrued royalty payables   $ 2,100   $ 2,200
Agreement maturity date Oct. 02, 2028      
Agreement maturity renewal description The Product Development Agreement will renew automatically for subsequent successive one-year renewal periods unless Scilex Pharma or the Developers terminate it upon 6-month written notice.      
Product Development Agreement [Member] | Developers [Member] | Minimum [Member]        
Commitments and Contingencies [Line Items]        
Royalty payment percentage related to future years 25.00%      
Product Development Agreement [Member] | Developers [Member] | Maximum [Member]        
Commitments and Contingencies [Line Items]        
Royalty payment percentage related to future years 35.00%      
Non-cancelable Lease Agreements [Member] | Minimum [Member] | Research and Development Facilities [Member]        
Commitments and Contingencies [Line Items]        
Operating lease, remaining lease term   1 year 3 months 18 days    
Operating lease, lease term   3 years    
Non-cancelable Lease Agreements [Member] | Maximum [Member] | Research and Development Facilities [Member]        
Commitments and Contingencies [Line Items]        
Operating lease, remaining lease term   1 year 7 months 6 days    
Operating lease, lease term   5 years